+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Bio/Pharmaceutical Outsourcing Report, March 2026

  • PDF Icon

    Report

  • 26 Pages
  • April 2026
  • Region: Global
  • GlobalData
  • ID: 6067790
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.

Report Scope

This report gives an important monthly update on the pharmaceutical outsourcing industry, based on analysis from the analyst's experts and our databases covering deals, companies, drugs, financials, news, clinical trials, and more. This report is required reading for:
  • CMO executives and strategic decision-makers: to improve understanding of the CMO industry and provide a critical input for strategic planning efforts.
  • Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
  • Investors, advisors, and consultants: they can gain a deeper understanding of the CMO market and important insights for identifying potential investment targets.

Reasons to Buy

  • Understand current trends and equip yourself with forward-thinking strategies to navigate challenges and capitalise on emerging trends driving the pharmaceutical manufacturing industry. Use our radar to identify developments and innovations with high impact.
  • Discover the latest opportunities and threats in the contract manufacturing industry, based on clinical trials and regulatory decisions.
  • Learn about the past quarter’s M&A and financing deals in the manufacturing space.
  • Identify the latest contract service agreements.
  • Develop your competitor or market intelligence by reading about inspection outcomes and facility investments.
  • Stay ahead of disruption with updates on supply chain obstacles and new regulations.

Table of Contents

1 Industry Trends
1.1 Eli Lilly expands manufacturing in China and Japan as GLP-1 demand keeps rising
1.1.1 Building local capacity for oral GLP-1s in China and expanding domestic production in Japan
1.1.2 Why these investments matter
1.1.3 How this fits with US reshoring rules
1.1.4 The bigger strategy
1.2 Rising geopolitical tensions in the Middle East threaten regional pharmaceutical supply chain and drug shortages
1.2.1 Pharmaceutical impact
1.2.2 Industry response
1.2.3 Country response
1.2.4 Outlook and implications
2 Industry Analysis
2.1 Contract service agreements
2.2 Contract manufacturing - opportunities and threats
2.3 Quarterly mergers, acquisitions, and financing - Q1 2026
3 Value Chain
3.1 API chemical
3.2 API biologics - cell, gene, vaccine, and virus
3.3 API biologics - protein and peptide
3.4 Commercial dose manufacturing and packaging
3.5 Clinical dose manufacturing
3.6 Analytical services
4 About the Analyst5 About the Authors6 Contact the Publisher
List of Tables
Table 1: Contract service agreements
Table 2: Contract manufacturing: opportunities and threats - potentially positive
Table 3: Contract manufacturing: opportunities and threats - potentially negative
Table 4: Mergers, acquisitions, and financing - Q1 2026
List of Figures
Figure 1: Contract service agreements by deal geography, by volume
Figure 2: Deals by deal geography, by volume - mergers, acquisitions, and financing
Figure 3: The contract manufacturing value chain

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 1315 Capital LLC
  • 3P Biopharmaceuticals SLU
  • 3SBio Inc
  • Aenova Holding GmbH
  • Agilent Technologies Inc
  • AGC Biologics Inc
  • Agno Pharmaceuticals LLC
  • Almac Group Ltd
  • Alpine Immune Sciences Inc
  • Ampersand Capital Partners
  • Andelyn Biosciences Inc
  • Anupam Rasayan India Ltd
  • Apozeal Pharmaceuticals Inc
  • Ardena Holding NV
  • Ardena Sodertalje AB
  • Atamyo Therapeutics SAS
  • Avid Bioservices Inc
  • Axplora Group GmbH
  • Bayer
  • Bavarian Nordic AS
  • Bespak Ltd
  • Beta Drugs Ltd
  • BioMarin Pharmaceutical Inc
  • Biogen Inc
  • Bilthoven Biologicals BV
  • BlackRock Inc
  • Bliss GVS Pharma Ltd
  • BNC Korea Co Ltd
  • Boehringer Ingelheim
  • Boehringer Ingelheim Pharma GmbH Co KG
  • Boehringer Ingelheim Pharmaceuticals Inc
  • Bora Pharmaceuticals Co Ltd
  • Bristol-Myers Squibb Co
  • C3i Center Inc
  • Catalent Inc
  • Catalent CTS LLC
  • Cellares Corp
  • Cell and Gene Therapy Catapult
  • Charles River Laboratories International Inc
  • Chiesi USA Inc
  • CStone Pharmaceuticals Co Ltd
  • CS Analytical
  • C-squared Pharma Sarl
  • Codis
  • Coating Place Inc
  • Coriolis Pharma Research GmbH
  • Dottikon Exclusive Synthesis AG
  • EDE / Emirates Drug Establishment
  • Eckert Ziegler SE
  • Earth Vision Bio Solutions, Inc
  • EirGen Pharma Ltd
  • Elpida Therapeutics
  • Eli Lilly and Co
  • EMA / European Medicines Agency
  • Eton Pharmaceuticals Inc
  • Esteve Pharmaceuticals SA
  • Esteve Quimica SA
  • Eurofins Scientific SE
  • Evotec
  • Exmoor Pharma Concepts Ltd
  • Flamma SpA
  • Forma Life Sciences
  • FUJIFILM Biotechnologies USA Inc
  • GSK plc
  • Genetix Biotherapeutics Inc
  • GlobalData Plc
  • Haleos Labs Ltd
  • Halo Pharma Inc
  • Hindustan Laboratories
  • Hovione FarmaCiencia SA
  • IDA Waterford Business Park
  • IDT Biologika GmbH
  • ImmunityBio Inc
  • Immedica Pharma AB
  • Informa
  • Ipsen SA
  • Jazz Pharmaceuticals UK Ltd
  • Janssen Biotech Inc
  • Janssen-Cilag International NV
  • Jetpharma SA
  • Jiangsu Jiaerke Pharmaceutical Group Co Ltd
  • Just Evotec Biologics Inc
  • Jubilant Generics Ltd
  • Jubilant Pharmaceuticals Incorporation
  • Kenox Pharmaceuticals Inc
  • Kymos Pharma Services SL
  • Kyron Bio SAS
  • Lek Pharmaceuticals dd
  • Les Laboratoires Servier SAS
  • Lilly Gateway Labs
  • Lonza Group Ltd
  • Locus Cell Co Ltd
  • MB Funds
  • Merck Co Inc
  • Merck Sharp Dohme UK Ltd
  • Merck & Co.
  • Meta? no
  • MilliporeSigma
  • Molecular Partners AG
  • MoonLake Immunotherapeutics
  • Nano? no
  • Nanologica AB
  • National Cancer Institute Instituto Nacional de Cancerología
  • Nivian Lifesciences Private Limited
  • Nikon CeLL innovation Co Ltd
  • Norgine BV
  • Novo Nordisk AS
  • Novo Nordisk Ltd
  • OncoC4 Inc
  • Organon Co
  • Patheon
  • Patheon France SAS
  • Patheon NV
  • PCI Pharma Services
  • Pfizer Inc
  • Pharmaron
  • Pharmatory Ltd
  • Pleiades Therapeutics
  • Pocono Pharmaceutical Inc
  • Praxis Packaging Solutions
  • ProBioGen AG
  • Purna Pharmaceuticals NV
  • Quell Therapeutics Ltd
  • Quotient Sciences Ltd
  • Rentschler Biopharma SE
  • Rechon Life Science
  • Roche
  • Roche Products Ltd
  • RoosterBio Inc
  • Samsung Biologics America, Inc.
  • Samsung Biologics Co Ltd
  • Sandoz GmbH
  • Sanofi
  • Sanofi-Aventis US LLC
  • Sanofi UK
  • Satellos Bioscience Inc
  • Sharp Packaging Services LLC
  • Shize Biotech
  • Siegfried Holding AG
  • Simtra US LLC
  • SK Pharmteco Inc
  • Southwest Research Institute
  • Sterling Pharma Solutions
  • Sterling Pharma Solutions Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sun Pharma UK Ltd
  • Symbiotec Pharmalab Pvt Ltd
  • Takeda
  • Tevogen Bio Holdings Inc
  • TerSera Therapeutics LLC
  • Therna Biosciences Inc
  • Tulex Pharmaceuticals Inc
  • Unimedic AB
  • University of Wisconsin Madison
  • Vetter Pharma-Fertigung GmbH Co KG
  • Vicebio Ltd
  • Viralgen Vector Core SL
  • Vista Pharmaceuticals Ltd
  • WuXi Biologics Cayman Inc
  • WuXi Biologics Co Ltd
  • WuXi STA Shanghai Co Ltd
  • WuXi XDC Cayman Inc
  • Yposkesi SAS
  • Zhejiang Xianju Junye Pharmaceutical Co Ltd
  • Zydus Lifesciences Ltd